226
Views
4
CrossRef citations to date
0
Altmetric
Drug Profile

GFF MDI for the improvement of lung function in COPD – A look at the PINNACLE-1 and PINNACLE-2 data and beyond

Pages 685-698 | Received 01 Feb 2017, Accepted 13 Apr 2017, Published online: 02 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Edward Kerwin, Paul Dorinsky, Mehul Patel, Kimberly Rossman, Colin Reisner, Andrea Maes, Patrick Darken, Dianne Griffis & Harald Fjällbrant. (2022) A randomized controlled trial of glycopyrrolate administered by metered dose inhaler in patients with uncontrolled asthma despite ICS/LABA treatment. Journal of Asthma 59:7, pages 1420-1432.
Read now
Omar S Usmani, Nicolas Roche, Martin Jenkins, Neda Stjepanovic, Peter Mack & Wilfried De Backer. (2021) Consistent Pulmonary Drug Delivery with Whole Lung Deposition Using the Aerosphere Inhaler: A Review of the Evidence. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 113-124.
Read now
Anthony D D’Urzo, Mario Cazzola, Nicola A Hanania, Roland Buhl & M Reza Maleki-Yazdi. (2018) New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2805-2819.
Read now

Articles from other publishers (1)

Somchai Sawatdee, Narumon Changsan, Teerapol Srichana & Basavaraj Nanjwade. 2023. Pulmonary Drug Delivery Systems: Material and Technological Advances. Pulmonary Drug Delivery Systems: Material and Technological Advances 131 175 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.